Confronting Pancreatic Cancer

Pancreas Cancer News Center

Pancreatic Cancer News and Archives

For access to the Select Abstractssm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

Search our News and Archives

Keyword(s) to Search:
Options:

Browse by Quarter

2009 | 1st Quarter | 2nd Quarter | 3rd Quarter

2008 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2007 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2006 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2005 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2004 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2003 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2002 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2001 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2000 | 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter |

2009 Third Quarter

Safety and Activity of Masitinib in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
July 1, 2010
...more

Surgical Treatment of Pancreatic Neuroendocrine Tumors: Report of 112 Cases
June 22, 2010
...more

Adjuvant Therapy and Survival after Resection of Pancreatic Adenocarcinoma: A Population-Based Analysis
June 15, 2010
...more

High Intensity Focused Ultrasound Ablation of Pancreatic Neuroendocrine Tumours: Report of Two Cases
June 3, 2010
...more

A Case of Complete Response (CR) to Combination Therapy of S-1 and Gemcitabine (GEM) for Unresectable Pancreatic Cancer
June 1, 2010
...more

Gemcitabine and Lenalidomide Combination in a Patient with Metastatic Pancreatic Cancer: A Case Study
June 1, 2010
...more

Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer
June 1, 2010
...more

Multicentre Phase I-II Trial of Capecitabine and Oxaliplatin in Combination with Radiotherapy for Unresectable Pancreatic and Biliary Tract Cancer: The CORGI-U Study
June 1, 2010
...more

Phase IB Study of Weekly Mammalian Target of Rapamycin Inhibitor Ridaforolimus (AP23573; MK-8669) with Weekly Paclitaxel
June 1, 2010
...more

Pilot Study of Irinotecan/Oxalipltin (IROX) Combination Chemotherapy for Patients with Gemcitabine- and 5-Fluorouracil- Refractory Pancreatic Cancer
June 1, 2010
...more

Potential use of the Anti-Inflammatory Drug, Sulfasalazine, for Targeted Therapy of Pancreatic Cancer
June 1, 2010
...more

Randomized Phase II Study of Gemcitabine plus Radiotherapy versus Gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-Fluorouracil for Patients with Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma
June 1, 2010
...more

Activism Among Exceptional Patients with Cancer
May 29, 2010
...more

Two Phase I Studies of Concurrent Radiation Therapy with Continuous-Infusion 5-Fluorouracil plus Epirubicin, and Either Cisplatin or Irinotecan for Locally Advanced Upper Gastrointestinal Adenocarcinomas
May 22, 2010
...more

Surgical Resection and Multidisciplinary Care for Primary and Metastatic Pancreatic Islet Cell Carcinomas
May 18, 2010
...more

Cigarette Smoking, Environmental Tobacco Smoke Exposure and Pancreatic Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
May 15, 2010
...more

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
May 14, 2010
...more

Beneficial Effects of 5-Fluorouracil and Heparin-Based Portal Infusion Chemotherapy Combined with Mitomycin C and Cisplatin after Curative Resection of Pancreatic Cancer
May 13, 2010
...more

A Phase I Study of the Biomodulation of Capecitabine by Docetaxel and Gemcitabine (mGTX) in Previously Untreated Patients with Metastatic Adenocarcinoma of the Pancreas
May 12, 2010
...more

Combining Gemcitabine, Oxaliplatin and Capecitabine (GEMOXEL) for Patients with Advanced Pancreatic Carcinoma (APC): A Phase I/II Trial
May 5, 2010
...more

Survival Following Resection of Pancreatic Endocrine Tumors: Importance of R-Status and the WHO and TNM Classification Systems
May 4, 2010
...more

Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma: A Multicenter Experience of the Gruppo Oncologico Italia Meridionale
May 3, 2010
...more

68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
May 1, 2010
...more

Capecitabine Based Postoperative Accelerated Chemoradiation of Pancreatic Carcinoma. A Dose-Escalation Study
May 1, 2010
...more

Factors Predicting Response and Survival after Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases: A Critical Appraisal of 48 Cases
May 1, 2010
...more

Incidence and Survival of Pancreatic Head and Body and Tail Cancers: A Population-Based Study in the United States
May 1, 2010
...more

Ten-Year Experience with Duodenum and Organ-Preserving Pancreatic Head Resection (Büchler-Farkas Modification) in the Surgical Treatment of Chronic Pancreatitis
April 30, 2010
...more

Second-Line Chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in Previously Treated, Unresectable Adenocarcinoma of Pancreas: The Final Results of a Phase II Trial
April 29, 2010
...more

Impact of Tumor Grade on Prognosis in Pancreatic Cancer: Should We Include Grade in AJCC Staging?
April 27, 2010
...more

Non-Steroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk: A Nested Case-Control Study
April 27, 2010
...more

Predicted Vitamin D Status and Pancreatic Cancer Risk in Two Prospective Cohort Studies
April 27, 2010
...more

Phase I Study of Preoperative Short-Course Chemoradiation with Proton Beam Therapy and Capecitabine for Resectable Pancreatic Ductal Adenocarcinoma of the Head
April 24, 2010
...more

Pancreatic Proteolytic Enzyme Therapy Compared with Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer
April 20, 2010
...more

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Response and Resection Percentages
April 20, 2010
...more

Alcohol Intake and Pancreatic Cancer: A Pooled Analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
April 7, 2010
...more

(68)Ga-DOTA-NOC PET/CT in Comparison with CT for the Detection of Bone Metastasis in Patients with Neuroendocrine Tumours
April 1, 2010
...more

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
April 1, 2010
...more

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital-Mayo Clinic Collaborative Study
April 1, 2010
...more

An Italian Study on Treatment Trends and Outcomes of Patients with Stage III Pancreatic Adenocarcinoma in the Gemcitabine Era: Is it Time to Change?
April 1, 2010
...more

Concurrent Gemcitabine and High-Intensity Focused Ultrasound Therapy in Patients with Locally Advanced Pancreatic Cancer
April 1, 2010
...more

Curcumin-Encapsulated MePEG/PCL Diblock Copolymeric Micelles: A Novel Controlled Delivery Vehicle for Cancer Therapy
April 1, 2010
...more

Efficacy of Radionuclide Treatment DOTATATE Y-90 in Patients with Progressive Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NETs): A Phase II Study
April 1, 2010
...more

Good Results after Major Pancreatic Resections in a Middle-Volume Center
April 1, 2010
...more

Intraoperative Localization of Insulinoma and Normal Pancreas using Invisible Near-Infrared Fluorescent Light
April 1, 2010
...more

Naturally Occurring K Vitamins Inhibit Pancreatic Cancer Cell Survival through a Caspase-Dependent Pathway
April 1, 2010
...more

Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients with Advanced Pancreatic Cancer
April 1, 2010
...more

Progress for Resectable Pancreatic Cancer?: A Population-Based Assessment of US Practices
April 1, 2010
...more

Radioembolization with Yttrium Microspheres for Neuroendocrine Tumour Liver Metastases
April 1, 2010
...more

Radiofrequency Ablation after Selective Internal Radiation Therapy with Yttrium90 Microspheres in Metastatic Liver Disease-Is it Feasible?
April 1, 2010
...more

Randomized Phase III Trial of Gemcitabine plus Cisplatin Compared with Single-Agent Gemcitabine as First-Line Treatment of Patients with Advanced Pancreatic Cancer: The GIP-I Study
April 1, 2010
...more

Phase II Study of S-1 in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancer
March 30, 2010
...more

Thymidylate Synthase (TYMS) Enhancer Region Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd Line Treatment of Advanced Pancreatic Cancer
March 23, 2010
...more

Phase I Trial of Gemcitabine Dose Escalation with Concurrent Tadiotherapy for Patients with Locally Advanced Pancreatic Cancer
March 20, 2010
...more

Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas
March 19, 2010
...more

Chemotherapy with 5-Fluorouracil, Cisplatin and Streptozocin for Neuroendocrine Tumours
March 16, 2010
...more

Surgery and Staging of Pancreatic Neuroendocrine Tumors: A 14-Year Experience
March 12, 2010
...more

Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surigical Exploration
March 12, 2010
...more

Chromogranin A-Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
March 9, 2010
...more

Parenteral Nutrition Support for Patients with Pancreatic Cancer. Results of a Phase II Study
March 9, 2010
...more

Pancreatic Proteolytic Enzyme Therapy Compared With Gemcitabine-Based Chemotherapy for the Treatment of Pancreatic Cancer
March 8, 2010
...more

Intraoperative Radiotherapy for Resected Pancreatic Cancer: A Multi-Institutional Retrospective Analysis of 210 Patients
March 5, 2010
...more

Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
March 5, 2010
...more

Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients with Advanced Pancreatic Cancer
March 3, 2010
...more

90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
March 1, 2010
...more

131I-Metaiodobenzylguanidine Therapy of Neuroblastoma and Other Neuroendocrine Tumors
March 1, 2010
...more

Adjuvant Chemoradiotherapy after Pancreatic Resection for Invasive Carcinoma Associated with Intraductal Papillary Mucinous Neoplasm of the Pancreas
March 1, 2010
...more

External Beam Radiotherapy plus 24-hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study
March 1, 2010
...more

Non-Functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients
March 1, 2010
...more

Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors
March 1, 2010
...more

Safety and Efficacy of Single-Day GemOx Regimen in Patients with Pancreatobiliary Cancer: A Single Institution Experience
March 1, 2010
...more

Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
March 1, 2010
...more

Salvage Therapy with (177)Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors
March 1, 2010
...more

Prognosis and Feasibility of En-Bloc Vascular Resection in Stage II Pancreatic Adenocarcinoma
February 28, 2010
...more

Palliative First-Line Treatment with Weekly High-Dose 5-Fluorouracil as 24h-Infusion and Gemcitabine in Metastatic Pancreatic Cancer (UICC IV)
February 26, 2010
...more

S-1 Monotherapy as Second-Line Treatment for Advanced Pancreatic Cancer after Gemcitabine Failure
February 26, 2010
...more

ABO Blood Group, Helicobacter Pylori Seropositivity, and Risk of Pancreatic Cancer: A Case-Control Study
February 24, 2010
...more

Plasma Pharmacokinetics after Combined Therapy of Gemcitabine and Oral S-1 for Unresectable Pancreatic Cancer
February 24, 2010
...more

Elevated Levels of CA 19-9 and CEA in Pancreatic Cancer-Associated Diabetes
February 20, 2010
...more

Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer
February 18, 2010
...more

The Global Impact of Endoscopic Ultrasound (EUS) Regarding the Survival of a Pancreatic Adenocarcinoma in a Tertiary Hospital
February 18, 2010
...more

Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors
February 17, 2010
...more

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
February 17, 2010
...more

177Lu-[DOTA0,Tyr3] Octreotate Therapy in Patients with Disseminated Neuroendocrine Tumors: Analysis of Dosimetry with Impact on Future Therapeutic Strategy
February 15, 2010
...more

Dissecting Racial Disparities in the Treatment of Patients with Locoregional Pancreatic Cancer: A 2-Step Process
February 15, 2010
...more

Quality of Life after Adjuvant Intra-Arterial Chemotherapy and Radiotherapy versus Surgery Alone in Resectable Pancreatic and Periampullary Cancer: A Prospective Randomized Controlled Study
February 15, 2010
...more

LigaSure for Pancreatic Sealing During Distal Pancreatectomy
February 12, 2010
...more

Gemcitabine-Based Cytotoxic Doublets Chemotherapy for Advanced Pancreatic Cancer: Updated Subgroup Meta-Analyses of Overall Survival
February 10, 2010
...more

Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients with Pretreated Advanced Pancreatic Carcinoma: A Multicenter Experience of the Gruppo Oncologico Italia Meridionale
February 5, 2010
...more

Advanced Phase I/II Studies of Targeted Gene Delivery in Vivo: Intravenous Rexin-G for Gemcitabine-Resistant Metastatic Pancreatic Cancer
February 1, 2010
...more

Feasibility and Safety of Radiofrequency Ablation for Locally Advanced Pancreatic Cancer
February 1, 2010
...more

Phase I Clinical Trial using Peptide Vaccine for Human Vascular Endothelial Growth Factor Receptor 2 in Combination with Gemcitabine for Patients with Advanced Pancreatic Cancer
February 1, 2010
...more

Phase II Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients with Advanced Pancreatic Cancer
February 1, 2010
...more

Staged Surgery with Neoadjuvant 90Y-DOTATOC Therapy for Down-Sizing Synchronous Bilobular Hepatic Metastases from a Neuroendocrine Pancreatic Tumor
February 1, 2010
...more

Survival in Patients with Pancreatic Cancer after the Diagnosis of Malignant Ascites or Liver Metastases by EUS-FNA
February 1, 2010
...more

Treatment with Tandem [90Y]DOTA-TATE and [177Lu] DOTA-TATE of Neuroendocrine Tumors Refractory to Conventional Therapy: Preliminary Results
February 1, 2010
...more

Phase I Study of Daily Irinotecan as a Radiation Sensitizer for Locally Advanced Pancreatic Cancer
January 28, 2010
...more

A Phase II Study of Isoflavones, Erlotinib, and Gemcitabine in Advanced Pancreatic Cancer
January 27, 2010
...more

Consumption of Food Groups and the Risk of Pancreatic Cancer: A Case-Control Study
January 26, 2010
...more

Conkiss: Conformal Kidneys Sparing 3D Noncoplanar Radiotherapy Treatment for Pancreatic Cancer as an Alternative to IMRT
January 21, 2010
...more

Importance of Age of Onset in Pancreatic Cancer Kindreds
January 20, 2010
...more

[(177)Lu-DOTA(0)-Tyr(3)]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney
January 12, 2010
...more

Phase II Study of Radiation Therapy Combined With Weekly Low-Dose Gemcitabine for Locally Advanced, Unresectable Pancreatic Cancer
January 8, 2010
...more

Estimating Optimal Dose of Twice-Weekly Gemcitabine for Concurrent Chemoradiotherapy in Unresectable Pancreatic Carcinoma: Mature Results of GEMRT-01 Phase I Trial
January 5, 2010
...more

Cisplatin and Etoposide as First-Line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas
January 4, 2010
...more

Family History of Cancer and Risk of Pancreatic Cancer: A Pooled Analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
January 4, 2010
...more

A Systematic Review of Resectability and Survival after Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer
January 1, 2010
...more

Clinical Response of Large Cell Neuroendocrine Carcinoma of the Lung to Perioperative Adjuvant Chemotherapy
January 1, 2010
...more

Combined Cetuximab and Trastuzumab are Superior to Gemcitabine in the Treatment of Human Pancreatic Carcinoma Xenografts
January 1, 2010
...more

Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial
January 1, 2010
...more

Definitive Chemoradiation Therapy with Capecitabine in Locally Advanced Pancreatic Cancer
January 1, 2010
...more

Erlotinib 150 mg Daily plus Chemotherapy in Advanced Pancreatic Cancer: An Interim Safety Analysis of a Multicenter, Randomized, Cross-Over Phase III Trial of the 'Arbeitsgemeinschaft Internistische Onkologie'
January 1, 2010
...more

Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer
January 1, 2010
...more

Outcomes of Adjuvant Chemoradiation after Pancreaticoduodenectomy with Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
January 1, 2010
...more

Survival Effects of Adjuvant Chemoradiotherapy after Resection for Pancreatic Carcinoma
January 1, 2010
...more

Efficacy of using a Standard Activity of (131)I-MIBG Therapy in Patients with Disseminated Neuroendocrine Tumours
December 17, 2009
...more

Neoadjuvant Peptide Receptor Radionuclide Therapy for an Inoperable Neuroendocrine Pancreatic Tumor
December 14, 2009
...more

Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
December 9, 2009
...more

A Phase II Study of Induction Chemotherapy with Gemcitabine plus S-1 Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
December 5, 2009
...more

Biweekly Gemcitabine (GEM) in Combination with Erlotinib (ERL): An Active and Convenient Regimen for Advanced Pancreatic Cancer
December 1, 2009
...more

Chemoradiotherapy with Concurrent Gemcitabine and Cisplatin with or without Sequential Chemotherapy with Gemcitabine/Cisplatin vs Chemoradiotherapy with Concurrent 5-Fluorouracil in Patients with Locally Advanced Pancreatic Cancer--A Multi-Centre Randomised Phase II Study
December 1, 2009
...more

Childhood Pancreatic Tumors: A Single Institution Experience
December 1, 2009
...more

Gemcitabine-Based Combination Chemotherapy Followed by Radiation with Capecitabine as Adjuvant Therapy for Resected Pancreas Cancer
December 1, 2009
...more

Phase III Trial of Chemotherapy using 5-Fluorouracil and Streptozotocin Compared with Interferon Alpha for Advanced Carcinoid Tumors: FNCLCC-FFCD 9710
December 1, 2009
...more

Neoadjuvant Chemoradiation and Pancreaticoduodenectomy for Initially Locally Advanced Head Pancreatic Adenocarcinoma
December 1, 2009
...more

Preoperative Nomogram to Predict Risk of Perioperative Mortality Following Pancreatic Resections for Malignancy
December 1, 2009
...more

Revisiting the ALA/N (Alpha-Lipoic Acid/Low-Dose Naltrexone) Protocol for People with Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases
December 1, 2009
...more

Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer
December 1, 2009
...more

Sunitinib Paves the Way for Targeted Therapies in Neuroendocrine Tumors
December 1, 2009
...more

Survival Data Justifies Resection for Pancreatic Metastases
December 1, 2009
...more

Dose Finding and Early Efficacy Study of Gemcitabine plus Capecitabine in Combination with Bevacizumab plus Erlotinib in Advanced Pancreatic Cancer
November 20, 2009
...more

Phase III Randomized Comparison of Gemcitabine versus Gemcitabine plus Capecitabine in Patients with Advanced Pancreatic Cancer
November 20, 2009
...more

Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination with Cisplatin, Docetaxel, or Irinotecan in Patients with Metastatic Pancreatic Cancer: CALGB 89904
November 20, 2009
...more

A Randomised Phase II Study of Modified FOLFIRI.3 vs Modified FOLFOX as Second-Line Therapy in Patients with Gemcitabine-Refractory Advanced Pancreatic Cancer
November 17, 2009
...more

Radiotherapy for Pancreatic Neuroendocrine Tumors
November 15, 2009
...more

Phase IB Study of Weekly Mammalian Target of Rapamycin Inhibitor Ridaforolimus (AP23573; MK-8669) with Weekly Paclitaxel
November 9, 2009
...more

Continuous 5-Fluorouracil Infusion plus Long Acting Octreotide in Advanced Well-Differentiated Neuroendocrine Carcinomas. A Phase II Trial of the Piemonte Oncology Network
November 3, 2009
...more

A Successful Two-Stage Treatment with CDDP and CPT-11 for Pancreatic Neuroendocrine Carcinoma with Liver Metastasis
November 1, 2009
...more

Elevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer
November 1, 2009
...more

Outcome of Upfront Combination Chemotherapy Followed by Chemoradiation for Locally Advanced Pancreatic Adenocarcinoma
November 1, 2009
...more

Phase II Study of Biweekly Gemcitabine Followed by Oxaliplatin and Simplified 48-h Infusion of 5-Fluorouracil/Leucovorin (GOFL) in Advanced Pancreatic Cancer
November 1, 2009
...more

Prognostic Implications of Tumor Invasion or Adhesion to Peripancreatic Vessels in Resected Pancreatic Cancer
November 1, 2009
...more

Refractory Neuroendocrine Tumor-Response to Liposomal Doxorubicin and Capecitabine
November 1, 2009
...more

A Phase I Study of Imexon plus Gemcitabine as First-Line Therapy for Advanced Pancreatic Cancer
October 24, 2009
...more

Risk of Pancreatic Cancer in Chronic Hepatitis B Virus Infection: Data from the REVEAL-HBV Cohort Study
October 16, 2009
...more

Antisense Inhibition of MicroRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
October 1, 2009
...more

Combined Liver Surgery and RFA for Patients with Gastroenteropancreatic Endocrine Tumors Presenting with More Than 15 Metastases to the Liver
October 1, 2009
...more

Diagnosis and Treatment of Pancreatic Vasoactive Intestinal Peptide Endocrine Tumors
October 1, 2009
...more

Enhanced Antitumor Effect of Combined Gemcitabine and Proton Radiation in the Treatment of Pancreatic Cancer
October 1, 2009
...more

High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience
October 1, 2009
...more

High-Dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
October 1, 2009
...more

In Vivo Activity of Gemcitabine-Loaded PEGylated Small Unilamellar Liposomes Against Pancreatic Cancer
October 1, 2009
...more

Liver Metastases of Neuroendocrine Tumors: Treatment with Hepatic Transarterial Chemotherapy using Two Therapeutic Protocols
October 1, 2009
...more

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation as Immunotherapy for Pancreatic Cancer
October 1, 2009
...more

Norepinephrine-Induced Invasion by Pancreatic Cancer Cells is Inhibited by Propranolol
October 1, 2009
...more

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors: A Report from the PROMID Study Group
October 1, 2009
...more

Review of Adjuvant Radiochemotherapy for Resected Pancreatic Cancer and Results from Mayo Clinic for the 5th JUCTS Symposium
October 1, 2009
...more

Second- and Third-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma: Feasibility and Potential Benefits in a Retrospective Series of 117 Patients
October 1, 2009
...more

Outcomes and Tolerability of Chemoradiation Therapy for Pancreatic Cancer Patients Aged 75 Years or Older
September 30, 2009
...more

Cigarette Smoking, Environmental Tobacco Smoke Exposure and Pancreatic Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
September 29, 2009
...more

2009
3rd Quarter
2nd Quarter
1st Quarter

2008
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2007
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2006
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2005
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2004
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2003
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2002
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2001
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

2000
4th Quarter
3rd Quarter
2nd Quarter
1st Quarter

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Donations
FAQ | Clinical Trials Registry | Research Resources | About Us

webmaster

©2000-2010 Pancreatica.org - All Rights Reserved
www.pancreatica.org